Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;49(1):116-23.
doi: 10.1002/hep.22606.

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans

Hashem B El-Serag  1 , Eric A Engels, Ola Landgren, Elizabeth Chiao, Louise Henderson, Harshinie C Amaratunge, Thomas P Giordano
Affiliations

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans

Hashem B El-Serag et al. Hepatology. 2009 Jan.

Abstract

Hepatitis C virus (HCV) may increase the risk of hepatopancreaticobiliary tumors other than hepatocellular carcinoma (HCC). Previous case control studies indicated a possible association between HCV and intrahepatic cholangiocarcinoma (ICC). Little is known about the association between HCV and extrahepatic cholangiocarcinoma (ECC) or pancreatic cancer. We conducted a cohort study including 146,394 HCV-infected and 572,293 HCV-uninfected patients who received care at Veterans Affairs health care facilities. Patients with two visits between 1996 and 2004 with HCV infection were included, as were up to four matched HCV-uninfected subjects for each HCV-infected subject. Risks of ICC, ECC, pancreatic cancer, and HCC were assessed using proportional hazards regression. In the 1.37 million person-years of follow-up, which began 6 months after the baseline visit, there were 75 cases of ECC, 37 cases of ICC, 617 cases of pancreatic cancer, and 1679 cases of HCC. As expected, the risk of HCC associated with HCV was very high (hazard ratio [HR], 15.09; 95% confidence interval [95% CI], 13.44, 16.94). Risk for ICC was elevated with HCV infection 2.55; 1.31, 4.95), but risk for ECC was not significantly increased (1.50; 0.60, 1.85). Adjustments for cirrhosis, diabetes, inflammatory bowel disease, hepatitis B, alcoholism, and alcoholic liver disease did not reduce the risk for ICC below twofold. The risk of pancreatic cancer was slightly elevated (1.23; 1.02, 1.49), but was attenuated after adjusting for alcohol use, pancreatitis, and other variables.

Conclusions: Findings indicated that HCV infection conferred a more than twofold elevated risk of ICC. Absence of an association with ECC was consistent in adjusted and unadjusted models. A significant association with pancreatic cancer was erased by alcohol use and other variables.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a: Kaplan-Meier Estimates of the Cumulative Incidence of Intrahepatic Cholangiocarcinoma by Hepatitis C Virus Status b: Kaplan-Meier Estimates of the Cumulative Incidence of Pancreatic Cancer by Hepatitis C Virus Status c: Kaplan-Meier Estimates of the Cumulative Incidence of Extrahepatic Cholangiocarcinoma by Hepatitis C Virus Status d: Kaplan-Meier Estimates of the Cumulative Incidence of Hepatocellular Carcinoma by Hepatitis C Virus Status
Figure 1
Figure 1
a: Kaplan-Meier Estimates of the Cumulative Incidence of Intrahepatic Cholangiocarcinoma by Hepatitis C Virus Status b: Kaplan-Meier Estimates of the Cumulative Incidence of Pancreatic Cancer by Hepatitis C Virus Status c: Kaplan-Meier Estimates of the Cumulative Incidence of Extrahepatic Cholangiocarcinoma by Hepatitis C Virus Status d: Kaplan-Meier Estimates of the Cumulative Incidence of Hepatocellular Carcinoma by Hepatitis C Virus Status
Figure 1
Figure 1
a: Kaplan-Meier Estimates of the Cumulative Incidence of Intrahepatic Cholangiocarcinoma by Hepatitis C Virus Status b: Kaplan-Meier Estimates of the Cumulative Incidence of Pancreatic Cancer by Hepatitis C Virus Status c: Kaplan-Meier Estimates of the Cumulative Incidence of Extrahepatic Cholangiocarcinoma by Hepatitis C Virus Status d: Kaplan-Meier Estimates of the Cumulative Incidence of Hepatocellular Carcinoma by Hepatitis C Virus Status
Figure 1
Figure 1
a: Kaplan-Meier Estimates of the Cumulative Incidence of Intrahepatic Cholangiocarcinoma by Hepatitis C Virus Status b: Kaplan-Meier Estimates of the Cumulative Incidence of Pancreatic Cancer by Hepatitis C Virus Status c: Kaplan-Meier Estimates of the Cumulative Incidence of Extrahepatic Cholangiocarcinoma by Hepatitis C Virus Status d: Kaplan-Meier Estimates of the Cumulative Incidence of Hepatocellular Carcinoma by Hepatitis C Virus Status
See this image and copyright information in PMC

References

    1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–714. - PubMed
    1. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41(1):88–96. - PubMed
    1. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol. 2006;37(9):1211–1216. - PubMed
    1. Donato F, Gelatti U, Tagger A, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control. 2001;12(10):959–964. - PubMed
    1. Kobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer. 2000;88(11):2471–2477. - PubMed

Publication types

MeSH terms